Uses of triplex forming oligonucleotides for the treatment of human diseases
US5650316A · kind A · utility
32Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 6, 1994 |
| Grant date | Jul 22, 1997 |
| Priority date | — |
| Expiry date | Jun 6, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel methods of treating anti-neoplastic and non-neoplastic cell proliferative diseases. The present methods involve administration of triplex forming oligonucleotides to humans to inhibit the biological activity of tumor necrosis factor. Also provided are methods of treating neuro-oncologic states and renal cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.